Distal Radial Access for Coronary Procedures

NCT06165406 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-12-11

No results posted yet for this study

Summary

Distal radial access (DRA) in the anatomical snuffbox (AS) is a relatively novel approach that can be considered an alternative to trans radial access (TRA) for coronary procedures. Several observational and randomized studies have established its feasibility and safety, with evidence of certain advantages over TRA, such as a reduction in hemostasis time, a lower incidence of complications at the puncture site, and a lower incidence of radial artery occlusion (RAO). Notwithstanding that a recent randomized study reported a similar RAO rate between DRA and TRA, several meta-analyzes confirm the advantages of DRA, despite a consistently higher crossover rate.

The objective of this observational study is to assess the performance of the procedure and to compare clinical characteristics in an all-comer population undergoing diagnostic or interventional coronary procedures.

The main questions it aims to answer are:

* Determine the success rate of DRA and measure the incidence of RAO in an all-comer population undergoing coronary procedures.
* Compare the clinical and anatomical characteristics of patients with DRA for coronary procedures and determine predictors of failure of access.

Conditions

  • Vascular Access Complication
  • Coronary Artery Disease
  • STEMI
  • Non STEMI
  • Angina, Unstable
  • Angina, Stable
  • Artery Occlusion
  • Hematoma
  • Procedural Pain
  • Procedural Blood Vessel Puncture

Interventions

PROCEDURE

Distal radial access

Distal radial access for coronary procedures

Sponsors & Collaborators

  • Hospital Universitario Torrecárdenas

    collaborator OTHER
  • Hospital Regional de Malaga

    collaborator OTHER
  • Hospital Universitari de Bellvitge

    collaborator OTHER
  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER
  • Hospital Arnau de Vilanova

    lead OTHER

Principal Investigators

  • Kristian Rivera, MD · University Hospital Arnau de Vilanova, Lleida Spain.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06165406 on ClinicalTrials.gov